期刊文献+

可溶性生长刺激表达基因2蛋白与冠状动脉粥样硬化病变的相关性 被引量:6

Correlation of plasma soluble growth stimulation expressed gene 2 level with coronary atherosclerosis
下载PDF
导出
摘要 目的 :探讨冠状动脉(冠脉)粥样硬化性心脏病(冠心病)患者血浆可溶性生长刺激表达基因2蛋白(soluble growth stimulation expressed gene 2,sST2)浓度与冠心病的严重程度、稳定性及粥样硬化病变复杂性之间的关系。方法:随机选取我院心内科2014年10月至2018年7月间因怀疑冠心病收治入院的204例患者为研究对象,由冠脉造影结果分为冠心病组(148例)与非冠心病组(56例),其中冠心病组进一步根据临床表现分为急性冠脉综合征组(acute coronary syndrome,ACS)(87例)、稳定性心绞痛组(stable angina pectoris,SAP)(61例);根据造影结果对冠脉狭窄程度进行Gensini评分,再根据冠脉斑块病变形态分为复杂病变和简单病变2个亚组。采用酶联免疫吸附测定(enzyme linked immunosorbent assay,ELISA)法测定血浆sST2浓度,进行统计学分析。结果:冠心病组血浆sST2浓度明显高于对照组(P<0.001)。ACS组血浆sST2水平显著高于SAP组(P=0.002)及非冠心病组(P<0.001)。ACS组中复杂病变患者的血浆sST2水平显著高于简单病变患者(P=0.001)。Spearman相关分析显示血浆sST2浓度与Gensini评分呈正相关(r=0.239,P=0.001)。多元逐步回归分析显示病变类型(简单/复杂)、血清肌钙蛋白(troponin Ⅰ,TnI)水平是血浆sST2水平升高的危险因素(病变类型:β=0.242,P=0.003;TNI:β=0.283,P=0.001)。sST2诊断ACS患者为复杂病变的受试者工作特征(receiver operating characteristic,ROC)曲线下面积为0.713(P=0.001)。结论:血浆sST2可作为协助判断动脉粥样硬化斑块稳定性及复杂程度的一种新的可能的血清学指标。 Objective To investigate the correlation between plasma soluble growth stimulation expressed gene(sST2)level and the severity,stability of coronary artery disease(CAD)detected by angiography and the complexity of atherosclerotic lesion.Methods A total of 204 patients of whom 87 had acute coronary syndrome(ACS),61 had stable angina pectoris(SAP)and 56 control subjects who had undergone coronary angiography(CAG)between October 2014 and July 2018 were enrolled.Patients with ACS and SAP were divided into simple or complex lesion according to the complexity of atherosclerotic lesion.Plasma level of sST2 was measured by enzyme linked immunosorbent assay(ELISA)and Gensini score was calculated.All data collected were statistical analyzed.Results Plasma sST2 level was significantly elevated in patients with CAD compared with the control group(P<0.001).Level of sST2 in patients with ACS was significantly higher than those of SAP(P=0.002)and control subjects(P<0.001).Plasma sST2 level in patients with ACS with complex lesion was significantly higher than those with a simple lesion(P=0.001).There was a weak positive correlation between plasma sST2 level and severity of CAD as determined with Gensini score(r=0.239,P=0.001).Multivariate stepwise regression analysis showed that complex lesion and serum troponinⅠ(TnI)level were independent factors of plasma sST2 level(complex lesion:standardized coefficientβ=0.242,P=0.003;TnI level:standardized coefficientβ=0.283,P=0.001).The area under receiver operating characteristic(ROC)curve of sST2 for the diagnosis of ACS with complex lesion was 0.713(P=0.001).Conclusions Plasma sST2 level can be used as a new possible marker to assess the stability and complexity of atherosclerotic plaques.
作者 张颖 樊子旭 刘华 马建伟 张敏 ZHANG Ying;FAN Zixu;LIU Hua;MA Jianwei;ZHANG Min(Department of Emergency,Shanghai Chest Hospital,Shanghai Jiao Tong University,Shanghai 200030,China;Department of Cardiology,Shanghai Chest Hospital,Shanghai Jiao Tong University,Shanghai 200030,China)
出处 《内科理论与实践》 2019年第2期83-89,共7页 Journal of Internal Medicine Concepts & Practice
基金 国家自然科学基金项目(项目编号:81370400) 上海交通大学医学院高峰高原计划--"研究型医师"项目(项目编号:20172028)
关键词 可溶性生长刺激表达基因2蛋白 动脉粥样硬化 冠状动脉粥样硬化性心脏病 冠状动脉造影 Soluble growth stimulation expressed gene 2 Atherosclerosis Coronary artery disease Coronary angiography
  • 相关文献

参考文献1

二级参考文献13

  • 1Bauters A, Ennezat PV, Tricot O, et al. Relation of admission white blood cell count to left ventrieular remodeling after anterior wall acute myocardial infarction [ J ]. Am J Cardiol, 2007, 100 (2): 182-184.
  • 2Sanada S, Hakuno D, Higgins LJ, et al. IL-33 and ST2 comprise acritical biomechanically induced and cardioprotective signaling system [J]. J Clin Invest, 2007, 117 (6) : 1 538-549.
  • 3Rehman SU, Mueller T, Januzzi JL Jr. Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure [ J ]. J Am Coll Cardiol, 2008, 52 (18) : 1 458-465.
  • 4Weinberg EO, Shimpo M, Hurwitz S, et al. Identification of serum soluble ST2 receptor as a novel heart failure biomarker[J]. Circulation, 2003, 207 (5): 721-726.
  • 5Weinberg EO, Shimpo M, De Keulenaer GW, et al. Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction[J]. Circulation, 2002, 106 (23): 2 961-966.
  • 6Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease[ J]. Am J Cardiol, 1983, 51 (3): 606.
  • 7Schmitz J, Owyang A, Oldham E, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-I receptor-related protein ST2 and induces T helper type 2-associated eytokines [ J ]. Immunity, 2005, 23 (5) : 479-490.
  • 8Bergers G, Reikerstorfer A, Braselmann S, et al. Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins to the IL-1 receptor[J]. EMBO J, 1994, 13 (5): 1 176-188.
  • 9Shimpo M, Morrow DA, Weinberg EO, et al. Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction[J]. Circulation, 2004, 109 (18): 2 186-190.
  • 10James L Januzzi, W Frank Peacock, Alan S Maisel, et al. Measurement of the interleukin family member ST2 in patients with acute dyspnea [J].J AM Coll Cardiol, 2007, 50 (7): 607-613.

共引文献19

同被引文献49

引证文献6

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部